Post on 20-Apr-2020
� �� �
������HIV�� ����������������
Mother to Child Transmission of HIV in Africa : To Overcome the Dilemmas
� � ���Naomi WAKASUGI
��������� �Research Institute, International Medical Center of Japan
����� : ����� HIV������� ���
�������� . : 00�1/� ,**,
! " �
UNAIDS !+"#$%&� ,**+�'� (# .,***
�� HIV��)*+,-��.%� / 1*� 0,,2+*��" *12134����#5�67+,8 ����) 9: ,,1**��; +/<=> �?@'AB/ 9:,,.**��*12134����#+,8 CD ,***�#�6EHIV#��6D�?@; (' 2*��� / 9:1*��;���� �?@D:'A,8FGH�I�? JK� 12134���� /<��LM��;� +30* ,/3 0N� +,***��DB" OP+33*#; +2*-QR67S7+D*� +320TU$B���� �E �' /<��LM��;VW#�X� YZ ,*+*C'#;[\# ,�=V#�,-]P%7+,," 0� +"8 ^�� � HIV�AIDSM� _! JK��"CD;#"` AIDS'abD AIDScL; ('+,-,*��� 12134����'; +,,+*��# d,-��.%7+,+"8 T $9#����#�e,�?@ fg`hi,j� HIV�AIDS;$e7;%%�+kl m&#�b7+,8.P#�?@ ���; 3*�*����'A,-" T-
OP� �?@ ���;'(n) ��� *&'AB�n) �' ��� l!#?9oB+p O� CD����,-`\q6$9-6Dj� ���� ����� .#�:;rO,/s *&#C'hi`0t�e%&�P�+T-#�,8
HIV ��#$%&�'(&�������%&�HIV ��)*�
12134���� 12#�e,HIV���;� ,
-�B'� ,/� 0.�# +�" `3i,�* 1O�@AB� u@v+wxFy'; .-.*� 0-3.+z.3.3�" -�b7+,8 T%P �{|7'12 ���;^4 � ���$B@vE� CD +/�,.< 5n`6}{,-� 12134���� ..O�{|7'5)$Bn) ���*v+8 T $9#Y~����#�e, ���� n)��#;�7�@ *A,8 5)OPn)� HIV��;n)OP5)� /% 2��+-��%7+,."8T HIV��#�{,n) 8�. 0Vulnerability" #;�#�� 9: 0; +" *A,-hiP%7+,8/%;C��<�=9:'A,8 n) �9*��� >?@*�+� A�� ����BC;DEF�� ����BC$BB+� G��']�OP���� STI 0)���"*n)#;�+� ��GE��?'HIV����`H�.%,�C*n);�+��?*/ IJ'A,8KL#���~�M ��*�N'�+T- JK-67 ��=��O)� /s� / JK P.%D Sex~Q¡#RB~{+T-� /67K�#¢�=�)=£S)� {��:^T�¤~� ¤=¥ UVn)- Sex*5)#;JWCD;�¦.%,� §�� Sex`5)#P¨'S�+�6#E+� Purification, Dry sex/"�)�X©�? )ª« O¬0"�'A,8T $9�8�) ®-�,@ *{|7¯¬ ����#° EO¬67+,T-*� n) ±+7;�?@ ��� !²`Y³'S7+�+Z´-�b7+,8
7)[\] : ����� 0µ+0,�20// ^¶_�·¸¹º +�,+�+��������� �"Fax : *-�-,*,�1-0., E-mail : nwakasu@ri.imcj.go.jp
,**, +» +/�¼`
0 +. "
�,**, The Japanese Society for AIDS Research The Journal of AIDS Research
00
�����HIV���
HIV ���������� �������� ���������� ���1������ HIV ���!"#$%���&�'()�*+,-.�/012 3Safer
Sex4 51� Abstinence 3674 #89���� � :;<=�>?�*+,-./0#@A1���� )���2� B��CD��EF�GH�IJK ��LM%1
���� � NONPQRSTU�VWX��YZ *+,-./0[���\�]^_�)B`#a��b�cd�e df�����cddf�ghT-i+
j�e 3k:&df4 lm�nB)#�� � 1%1RSTU�eo&pqrst��cdlm#�\�\uv$��wB������x2���&�� dfghT-i+j#Ey��� z{t���y| 3Window period4�}~�h��&���df���#���� �
+ RSTU�t�YZ ,*+* �� / ������[��� AIDS ���
, RSTU�t�YZ ������ HIV ��[
The Journal of AIDS Research Vol. . No. , ,**,
� +/ �01
������������������ ����
HIV��������
������������������� �� !"#$�� %&� '�()� '���*�+,-./012� 3456/783�� HIV9���:������;� <��=>-./� ,�?@"� A� �� ���� &���� ����-B@C6D�����=>-./��6/B�:E/���F��C-FG�56/B���H����� ��:���I�� �H 2�+/J�
��FHIV�IKL8-B@�M+*, ++��HIV�I����&��� /*��HIV�I�L8+,�� ��B�� �CD.�I trophoblasts��HIV��+-� ��M�N�����������&����� �����F&�O��P"�Q
R����S"TD6�HIV+.� O�F� �!"��U#:��� ��B�VWCXC-"?L/#C�-YZ�6�� C�["��I-./�����S��HIVF� ��B�$I�\S�"TD6�HIVF]^I"%"� &'"� %_"��.8`a� ��"��:�-B@��I�YZ�6�FbD<6Oc�.8�M��B���"�d&�� HIV�I�����OVXC-� ��B��Hd&eD�HIVfI�L8�Fd&�"HIV"��.8gh���OVXC-"?�������+/�+1��i]�����"j(O�/8���kl��)�*e"� ��em��)-./<6n6�Hm� o&m� d&�-B@C-97�� .�.C�?@��)�N6"�8������.8em�+,�.p.pXq�.BC-F��� 8-Zpr-st��Auv"?���wRSxy"?������ ����F� o&m���
� + z{|}�~I� HIV��"�:���I
+� �.!/01� \S� HIV23�����?;9�B�� ����!"4F$I"0�E�B�� 5*�� 6�7� STIF�B�� |�����N"?���8R�klF�B�
,� ��/��I� ����9� ����:�;�klF�<�B�� ��{�=�����=��=d.�>?<��@B-���� ���8��A �
-� ¡l/�I/¢£I� B�¤� Fidelity ; C�D¥¦§-�I�E�56X.¨©F56��� $IF Teen age�ªB~IO«¬®F���� ~I��¯�°=±� Safer sexOG²:��FXq�.B�� ³G568H:/IF�B�� IJ/I´µ Female genital mutilation, Dry sex, “Purification”�
� , HIV������-��§K
e m � � � � § K
�Hm A���� ]^��
ARV ��
o&m �� Auv"?���wRSxy�&� �����S�RS"�F¶6��]^�� ·mL"�
ARV ��«M/N¸¹s�º»
d&� ���RS �O¼�
��O����ARV ���
+0 �
N Wakasugi : Mother to Child Transmission of HIV in Africa
02
��������� ,0���� ��������������������������������������HIV� �!"�#�$%��&'(
����� )�*+���,� � ��� IgGFc-./0123��� ������ Immunogloblin G 4IgG5 �67�8���� 9�� � ����679HIV9�:�;��"���� <=>�� +/�?@��9�� ��HIV�������� AB��+25� ��HIV�����2���������� CDEF������� PCR 4Polymerase Chain Reaction5 � ��������+3, ,*5� HIV proviral DNA2��)� PCR � ���,G���H��I��JJ�K�������8�,+�,-5��L"���M���N)�:� O� PCRPQ�R�I������=����=>��H�2��)�O:�S��8� 4 -5�:OT� PCR��U�V�WX�YZ2!":�#�[\�$��]^_`�ab�8��8TU�� :�Uc%�&d)�� ]^_`��,��' ()e�L�f*+�\�,.5� K�,-:�> .��U�[���.�'�,/�,15� [�9-ghCDEF/2AUO:Wi�� �jkl�bmS��$���=>O'��"n2G�)o0p�q�'�rN 4�:B(s����1��2t�)� ��2�����)�� �R5 u��H��R'v&�wQ�2�'���2x>�LO:���� K���
� � 3��H��_Fy��z{:�>� +/�?��9�� ��=>��� 4����|�� u��H��0)�56wQ � 0D}~�2�B� PCR��=>�j7��8�)�O:�� j!":���
HIV���������
�,���56S��[�:�>9:�' ���� � +33.;�N. Engl. J. Med�< �'� PACTG 4Pedi-atric AIDS Clinical Trials Group5 *10/hg�1E���'�wQ�=2<�>��,25� O' 9-ghCDEF/4Antiretroviral ; ARV5� ZDV2>? +.W�>@�H�AB�� CD�����E��F@�HGHAB� ����I���[ 0�H�AB��O:��=>� ���,G�HIV��2 ,0��� 2��t�)O:��|�� :�U[��8=��O�$� J�3K2!":�#�[LM������:�>()e�bm�'��U��=��� N��8B����O�Lbm����P�[Q*��RXe� �:�Rba�S�8=�� K���O�8: ARV�AB��I�� AB��� �����,G�AB���� ARV��T�R��=>�@�@��01~����7*'�O::�=�� ]^_`��U��<RXe�P���[��:��,��56��U�|� ARV�AB���V�����'�PQ� 0D,35� W]^_`-*5�� Trial��>? -0W�� ARV2AB)� Short course�$��[XY�wQ�2�'�O:�*�=>|�� ����I��� -Z���: 0�AB�[��'� 4\ -5�V$� H��������� ��� �������H��[��]^_`� ��j\� 43�,���-*/*�5 O:���'��U��=>|>-+�--5� ARV2A���UB� �����2���� )�*+]��2^=>BB� :�U56¡_�q'�()e:� K'��|���<RXe:�¢£ ¤¥¦��O::�=���,��' 4ARV�A�5 ��M�§`()e 4+.
� - DNA-PCR� �I�:PQ��� HIV���0D}~����
PCR� I� 4��5 ��H���
+ day ,0weeks ¨+*weeks
�©©
��©
���
,ªa�H����@� ����
� . ]^_`�J&� HIV�,���«¬2BB�®n,
� � " n >?E�I"n b¯CDEF°c"n
STI 4de�R51��± 4²³_]�f��5g´�hi�Nµjk´�l�VitAHIV�)7�m¶���·U=n��o¸J��� 4p¹ ,*M5
��E���qrE�sºtuvw¸x»��g�����HfEy
��µz HIVCDEFk�� CD.� T_~�¼{CDEF��|HIV subtype
The Journal of AIDS Research Vol. . No. , ,**,
4 +1 503
,/�� ������� ,+.-�� ��� ��������,.������������������ �������������� ��!"#�$%&'�(�)* �+��,���)� +333� -� Epoch-making��.��/0�� ��1-'* 2345��67��8) /0�* ��9:;<=>��?@AB4 Nevirapine ; NVP�+C�� ��DEF��GH-.� I -�* ��J�����)8�*��K��� Exclusive Breast Feeding� L����;<=>���DEF�'MN�;<=>��O8�)P�* QRS�� ���T<U��V�� �W�XY�Z)P��L��.���-/��2345)8�NVP�.'* HIVNET*+,trial�[O0����GH��\]^_�`abcde���NVP-0�
fg���hi��j�� ,**mg� * kl: 'lm
1,i�n! NVPf ,mg�kg�0� +Cop�V��(������� �0q�� ZDV�rjs .t���* u�� ��p0v�8�(�w* xyz $L� Stigma�{(��('"|u}��~���(!"�'��#�4��Z(�(����P�� q������'1�D��� ,02 US�))�� ��NVP��R' . US���� �����-1��
�����HIV������ �������������
���� + �����������S�'�:f���EF�|�#)8��L�GH���* $ �����%80�(�&'���'��S� ��(�� ��:�(���(��'���67��/0J(�-2�� UNICEF���)* ������
� - GH��+/0� HIV�DEF�� ARV�����4
� / ��K���� Exclusive Breast Feeding� � HIV�DEF������z�
+ ,¡¢|£�¤¡f-0�(�./0¥���¦§1¨�©ª
, (.!«¢¬�X�,¡«¢�.#��2|3®f¯8L�.! pHf�°J* CD.4^«5�±^²| HIV�/0�2f¯8L
- ��6�7³´D IgA, G, Lactoferin, Lysozyme, Macrophage��� fµ{/¶�
. �·�P¸¹Subclinical Mastitisf���* �º«5 tight junctionf©ª/¶��6�2y<�µ»f�¼
+2 �
N Wakasugi : Mother to Child Transmission of HIV in Africa
1*
� -*�������������� ����� ��������������� ����������� �! ��"#�� ��$�� � ! ����%&'%�%(�)*�+%,�($� ��+�-%�.+��! ��/$0����1! ��#�23� ($��"��2! ���������.4��5 " ,*�6�%,�($-37� 0�89%�:; HIV�AIDS�(9<��� !��=& >$�?��@HIV<��>$�����+�ABCD#E
F%("G�##H$0��! $� � �%�$&'() >$+"��=�1! �I0�#J9�+���� ��2�K*�K+#,,�($�/%=L-M+NCO+.P�H�%(QR�S�/0��! +7 NCO�TU >$�(9VW�K*! ,7 ��#3FX%(12Y��)� Stigma Z�����3[#\���(%(�(97! -7 NCO##H$12]^B_�(9 Stigma! .7 ��#J,���`CDDab��/+��#c@X$0�Y�d4! K+�>$� /7 efg��5%(h6%7�-8c9:! ;�<�=>�i1��(� 07�-+NCO#�?�@�2#H$�@��AY�j�cBC�DE��($� %� >$� /7 c 07+kF��! NCO+��0�+8PHIV���<�G�l�X��! g���7 m,�NCO��@+;H��2%,����IJGKL�l�%�,��(9no����Mp.*7">$�0�89%�: ! ?�HIV��<�#'q+�N
(0��O�,�(�"! ��#c@XNCO#Pr0������ ��sDtQ+u(� �%(�! �(9v�(QR�S+R"�w,�(��! x�/I�yS�z�89+{H����! �T�U����! |�}������~V����\+�(��Mp >$-/7���~V��W�(9���X+������7H"#H%(�(9"� >$�.+7! #H$���HIVABCD#E� ($�+"k=�1! %�HIV<�G�NCO8P�2%�%(�(9�\�Y���#Z�/$�@+�! [!�! ��.�\��]�!^��Z�! ���]��2+�(�B$_`�>$.,, .-7� Melanie M Smith��ab+c�(�..7! ?�d$��o_��e /
+F�@�$� /%=L! [!� � f! g\�������2�h2i�2�j��(�! \kl}����(�($� 0���/� IgA%�TO�mn#�o/$�+�p��8(�! �mn�qr+�s(� ����#t&�($�\kl}���F"%2��u�$�! NCO�v! d��v �0�}���u��w$� ?��@HIVABCD�qr�c/2%$� F�����#t&$�! 8(\�efx���\ pH"h2
8�$� 0�y+���&#��+>�H$0�+8P! �z9,{c Subclinical Mastisis./7� !#'q0�� �! ?��@��������/+�J/$ABCD|#h2�H$0�� �$� �}� H�$��~V��W�]�!^���� >$����0���~V��W�ab�¡">��%d4�>$� ?���~V��+¢~/$>FP! 7#£�"#H%(�\��"#�7+�L(�X��F,�P!HIV<��J������OY%(������ ����vDN! �w¤#"��/¥¦�>$0� >$� ��"��vDN�� �%2! HIV<�12���##H$0�+8P!�.4���/$�(9Mp"Y�($.07�F���~V��W#�§� +�� �$����+5%(�¨=�($-37� ��~V��W#P�����§+© ?#-�+����($�#-�@! ª«b��A��%(89+©����89%� ¬��/$L��SF$�! HIV��<�&'�®�«¯°���� "(#�2_`��! ���� �?0F (�F=,�(%(�(9��±� >$� e 0+�/89%! ���²�%��HIV��<�#��/$y��W+8$��".�$�0�Mp�>������±� � Feeding counseling
#���+J(��! NCO?³���! ´�#� ��9H �+?�P¡#¢X$0��J=�($� ��! NCO(1#P��+�µd��v�¶"�(� ?#�%(89+! ��ª}BD��($���2%,�($� F�8Ph6! ·!�+NCO��#/$�@+;�<#£=1+¸b�#£9�W" UNICEF+8P¤¥! ����($�">$����� , ������ �����
+33.�� PACTG*10�«�¸�C�¦! $�����HIV§2�O�P��(! >$(��¨>$%�+��=�1! 12K0�©ª��� ARV#£(«@! �/�ABCD|�l5+¬@$! Y���O% ARV#��¹+#H$�¹+! Elective Cesarean Section ZP¡�º.�7.17 J(! [!�+���� �#H%(! �(989+��<�#'q�@+8(0��6�J=$�»
� 0 HIV��<�#��/$�W
+¼ ��#c@®¯�� Z°NCO! ±�7,¼ ².�����-¼ HIV<���(%(y�12���.¼ �³Z��/¼ ��~V��0¼ Clinical & subclinical Mastitis�©ª���
The Journal of AIDS Research Vol. . No. , ,**,
Z +3 71+
������ �������� ��������+.+������������������ �������� �� !�� �"���# $%&'� �� ()!*+����,*-��.�/012� ���3*���4�56� ARV�78*-��9�# �:���;*+�<� �="# >��;�?�9 ARV�����# @ABCD:������ ��� ARV���5� ARV;E !*��FGHI�J��# "K=�����L,*!456��6!�*-�� ��*��#= M-0$N��O P�%�5����Q��4R4�P��&'���*����()�*-�� )KS! ARV�78*-��9���ARV���*+����6��T**-��*# UVW;+���X)���,Y�# HIVZ[VA;\��%;# -.;/�56�0�*���X�,�]�)���,*-�� H)���&'�������9# 12��HIV���3G�4R�# � !�HIV��;5���4^# �6*���4^��67�5� �_[`a�b��cR�� ���8+�$%&'�-�� 933*���d���4���,Y*!# HAART MHighly Active AntiRetroviral TherapyO �5��# � !�7e:���f)�R*�d�ghI���6*i�6R��+�����*-����56�*i*# �jk;4�!l!);����)
l��9�jk�m Test for what?� -��� ��<�6n��# � !;=,� 6?�m� ��6>o?p�6R�@q?�� ���H)�4=jk;A)I# ;BCbHI# Stigma;rDHI����s����4�4���&E���*���� !:���L,*-��E�����!# �����;F��*����# �GH�tX�� Iu��56�$%&'���*!J�����(���;Kv*����6LI�-�� H)�/012*�# wM�7�HIV����5��:K;N6OPH�Qx�yD4# zR�{|# 3}S7�{|����!5�*i�6R����� ��56�T# ��~U���A*�VW5�!# I9�X�YZ# � !�(��_[`;�+����# ��6[�\C�]^�_�H����� ���>o`��)����$%&';��4�,�]�)��ab�-������� ����� vs���� vs����
,**+P .�c/*�_[`@��d�V�e��Q�_[`d8��f���g�:���;hd���ij�Kkl��m9HI�������L�*-��� 4�4# +�/ .US���6no�p8*4�!)Kq��������� +����*rs��;ts���u9)��NVP�v��-�# ��w���7�3*����
HIVjk 4�\�������4����*����#��6wM����)�.�# x��4=�RT�y?�v��z{H��|�})H��� Z�&��~*� +���S�K�� +.QT -Q# � ,*�� 0$"N��x��RT��)��.2O� �$"�%�V*x��J����6���# x�Z[VA��%;�4���:���;\9# �x�Z[VA;[����HI�������d�# ��K��X���)K��>X������6��*-��NVP;>6�>�����¡����*i�# ~Q-
���.����H����\Q�j��g�:��; �56�?�Y�I�G�����6# +�9�TZj����¢;\v*��� x�Z[VA�����g�:�8+���*-�# �,�£+*-��# ���9�¤������;�����6�!# ��4�56�~Q���65�[����?���*-��WHO�UNAIDS�UNICEF�UNFPA�HIV�����¡?���}�¥;l��z+# NVP>��s���A¦&A;j�4�+�� ,***P +*� ++§+-����}�¥�5�`���R�.3O *�# Z�&��~;+,��R*�����^x�Z[VA�no�f�%�V�R*D�4�����6v�/*O;!��4��)# x�RT�¨�¤���©��-�# 4�4��5�!HIV
����;*+��ª0«¬B�6�m9H����6!�*-���
��������
N�# /012�HIV����;e�®�*i���T�-�¯�# ¯�# $%&'�s��°o4�� ��±s�$%&'�²³�4�d�4�����/012���X� ��¯� *-^6� $%&' +��%����9�UVW�+X�]# $%&' ,�����E�����9�J´�-�]# �±�B1%&'���� ARV;>6���*+�]# ���� �������!g�*���� � 1��4���# 3� +Q-��P"��µ��)¶� ,§.*US�*-�/012 3����# +Q-�� 1,***§,*,*** US�;¡_�?�HAART�¢¤�����£*-�# ,**+P .��_[`@��d¤·�¡?�¸%B1/�V M@��d�¥¦¹§;º� +331P
� 1 ARV M»%B�Z[VAdO ����¨�
NVPSingle dose
NDVShort course from -0w
HAART+ year Tritherapy
.US� ,02US� 1,***§,*,***US�
/012�3� +Q-��P"�µ��)¶¼,§.*US�
M ,* O
N Wakasugi : Mother to Child Transmission of HIV in Africa
1,
�������������� ���������� ��� -3������������ ,**+ .������������ � ����������!"��#$%�����&'()�*+)#��, �-)��������./$���$� 3*�01�234�5%67� "8 ($�9�:;%-(���<*#�� EU=� �>�?@$A% +331 �B"��� ����CDEF�GH��I� JCDEF���KLM �-�� ,**+ 0��N�CDE����% O 1*P+**QRS� J��CDE��TKLM � ����UV64�� "��./$��� W�� ARV
� !"X�#�$��(� ��Y2 AIDS��I�ZL�%�&A�2*)'[�� ����W(�N� CDEZL�\*�)�)]�^*+,��2���(� CDE� J�-_M �`,� UNAIDS�<��*�34�$�a� . Ob4 c�d(e$�%-���� ���f���<*#Ng���<(hijkS#/f�$�f��)� ���0N�12�HIV�CDE�Nl34�m3(nop5%-()6Iqrst�BI��) 78�9d(� Ng��a���u:a J;v=wxM $�Jy<)=>M z)?A$b*)�*/f�{�4(���<*#|}�GH)���@�a*~)/�8�d�fA� � BCz�u��HIV��)�����h�Voluntary Counseling & Testing : VCT, �D�%-�*�VCT �E)���F��F��)��f3I��G#C�t�j�D�t%-()�34���� H���E2/�I7(���/��aJK� L�64��(/*,� ��M5��N#�����h�K�.� OH�<(u����)b���jRks��2* VCT � '�HIV����%a�P��QR��(8A� �S���>��j��h) T. #(¡U)¡¢�£���(� V¤�Q�EW=HIVF���I�ZL��4$�#¥)$#(�%-4e� HIV�F�����#a��d(� %f(8AX�[¦�YZ��������a[G)#(�;g�§�¨����\�QR�]^64�f�)�*_©�`a �� VCT�D��-��)�34��(� ��<*# VCT�bc�����H���$�u���uª��a�)�f�.(�)�<"4(� Ng��� dcN� ���%���<*#A�z�=>�«)$G7�2.[G�-()¬7(� b��� HIV���-)«a$e#�)�* JfM �s�j®% #.� ¯g�z�h°&A)�E�±i� jg��²³=kl��Q�X¦m�)��� ´n%-4e ARV�<(µCDEF��@Hz� uª#g�Q�E¶� b��¤·az�V¤�Q�E#·� =4(p �.6¥-(�8� )�* JoM�s�j®�p�iA([G�-(%-�*�
� �
+ , AIDS Epidemic update December ,**+. UNAIDS ,**,.
, , Per cent of infant deaths due to AIDS, projections for
the year ,*+*. The progress of nations. UNICEF +331.
- , Peckham C, Gibb D : Current concepts : Mother-to child
transmission of the human immunodeficiency virus. N
Engl J Med --- : ,32�-*,, +33/.
. , Padian NS, Shiboski SC, Glass SO Vittingho# E:Hetero-
sexual transmission of Human Immunodeficiency Virus
(HIV) in northern California : Results from a ten-year
study. Am J Epidemiol +.0 : -/*�-/1, +331.
/ , Zambia sexual behaviour survey +332. Central statistical
o$ce, Ministry of Health Zambia, +333.
0 , ¸q#�{ : FGM������A(;5)V¤�T�I7(¹º» Ng�T¼� +- : 0/�1.� +333»
1 , Piot P, Laga M : Epidemiology of AIDS in the develop-
ing world. In Textbook of AIDS Medicine. Baltimore,
MD, Williams & Wilkins, p +*3�p +-,, +33..
2 , Closing the condom gap. Population Reports Johns
Hopkins School of Public Health, Vol ,0, Series H,
Number 3, April +333.
3 , Remington JS, Klein JO : Infectious Diseases of the
Fetus and Newborn Infant. /th edition. W.B. Saunders
Company, ,**+.
+*, Lewis SH, Reynolds KC, Fox HE : HIV-+ in tropho-
blastic and villous Hofbauer cells, and hematological
precursors in 2 week old fetuses. Lancet --/ : /0/�/02,
+33*.
++, Sprecher S, Soumenko# G, Puissant F, Degueldre M :
Vertical transmission of HIV in +/-week fetus. Lancet , :
,22, +320.
+,, Langston C, Lewis DE, Hammill HA : Excess intrauter-
ine fetal demise associated with maternal human im-
munodeficiency virus infection. J Infect Dis +1, : +./+�+.0*, +33/.
+-, Amiehessami-Aghili N, Spector SA : Human immunode-
ficiency virus type + infection of human placenta : Poten-
tial route of fetal infection. J Virol 0/ : ,,-+�,,-0, +33+.
+., Kovacs A, Chan LS, Chen ZC, William AM, Muder-
spach L, Young M, Anastos K, Levine AM : HIV-+
RNA in plasma and genital tract secretions in women
infected with HIV-+. J Acqui Immun Defic Syndr ,, :
+,.�+-+, +333.
+/, Colebunders R, Kapita B, Nekwei W : Breastfeeding
and transmission of HIV. Lancet , : +.21, +322.
The Journal of AIDS Research Vol. . No. , ,**,
� ,+ ,1-
+0� Lepage P, Van de Perre P, Carael M:Postnatal transmis-sion of HIV from mother to child. Lancet , : .**, +321.
+1� Zeigler JB, Cooper DA, Johnson RD, Gold J : Postnataltransmission of AIDS-associated retrovirus from mother
to infant. Lancet + : 230�232, +32/.
+2� Bobat R, Coovadia H, Coutsoudis A, Moodley D : De-terminants of mother to child transmission of human
immunodeficiency virus type + infection in a cohort from
Durban, South Africa. Pediatr Infect Dis J +/ : 0*.�0+*,
+330.
+3� Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J,
Handelsman E, Brambilla D, Moye J, Ho# R : Diagnosis
of infection with human immunodeficiency virus type +
by a DNA polymerase chain reaction assay among in-
fants enrolled in the Women and Infants’ Transmission
Study. J Pediatr +,3 : +32�,*1, +330.
,*� Delamare C, Burgard M, Mayaux MJ, Blanche S,
Doussin A, Ivano# S, Chaix ML, Khan C, Rouzioux C,
and the French Pediatric HIV Infection Study Group :
HIV-+ RNA detection in plasma for the diagnosis of
infection in neonates. J Acqui Immun Defic Syndr +/ :
+,+�+,/, +331.
,+� Bertolli J, St. Louis ME, Simonds RJ, Nieburg P,Kamenga M, Brown C, Tarande M, Quinn T, Ou CY :
Estimating the timing of mother to child transmission of
human immunodeficiency virus in a breast-feeding popu-
lation in Kinshasa, Zaire. J Infect Dis +1. : 1,,�1,0,
+330.
,,� Zijenah L, Mbizvo MT, Kasule J, Nathoo K, MunjomaM, Mahomed K, Maldonado Y, Madzime S, Katzenstein
D : Mortality in the first , years among infants born to
human immunodeficiency virus-infected women in
Harare, Zimbabwe. J Infect Dis +12 : +*3�++-, +332.
,-� Kevin MD, Fowler MG, Mercier E, Vincenzi I, Saba J,Ho# E, Alnwick DJ, Rogers M, Sha#er N : Prevention
of mother to child HIV transmission in resource-poor
countries. JAMA ,2- : ++1/�++2,, ,***.
,.� The Working Group on Mother-to-Child Transmissionof HIV : Rates of mother-to child transmission of HIV-
+ in Africa, America, and Europe : results from +- peri-
natal studies. J Acqui Immun Defic Syndr 2 : /*0�/+*,
+33/.
,/� Bulterys M, Chao A, Dushimimana A : Multiple sexualpartners and mother-to-child transmission of HIV-+.
AIDS 1 : +0-3�+0./, +33-.
,0� Lepage P, Van de Perre P, Msellati P : Mother-to-child
transmission of human immunodeficiency virus type +
and its determinants : A cohort study in Kigali, Rwanda.
Am J Epidemiol +-1 : /23�/33, +33-.
,1� John CG, Nduati R, Mbori-Ngacha D : Genital shed-ding of HIV-+ during pregnancy : association with im-
munosuppression, abnormal cervical or vaginal dis-
charge, and severe vitamin A deficiency. J Infect Dis
+1/ : /1�0,, +331.
,2� Connor EM, Sperling RS, Gelber R : Reduction of
maternal-infant transmission of human immunodefici-
ency virus type + with zidovudine treatment. N Engl J
Med --+ : ++1-�++2*, +33..
,3� Lallemant M, Jourdain G, Le Coeur S : A trial of short-ened zidovudine regimens to prevent mother-to-child
transmission of human immunodeficiency virus type +.
Perinatal HIV prevention trial (Thailand) investigators.
N Engl J Med -.- : 32,�33+, ,***.
-*� Moodly D : On behalf of the SAINT trial : Nevirapine(NVP) versus zidovudine(ZVD)�lamivudine(-TC) inprevention of peripartum HIV transmission, Abstract
LbOr,, +-th International AIDS Conference, Durban,
South Africa, 3�+. July ,***.
-+� Van de Perre P, Simonon A, Msellati P : Postnatal trans-mission of human immunodeficiency virus type + from
mother to infant. A prospective cohort study in Kigali,
Rwanda. N Engl J Med -,/ : /3-�/32, +33+.
-,� Maguire A, Sanchez E, Fortuny C, Casabona J : Poten-tial risk factors for vertial HIV-+ transmission in Catalo-
nia, Spain : the protective role of cesarean section. The
working group on HIV-+ transmission in Catalonia.
AIDS ++ : +2/+�+2/1, +331.
--� Nicoll A, Newell ML, Peckham CS : Breast feeding is amajor factor in HIV transmission. BMJ -,+ : 30-, ,***.
-.� Guay LA, Musoke P, Fleming T, Bagenda D, Allen M,Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M,
Emel L, Mirochnick M, Fowler MG, Mofenson L,
Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB :
Intrapartum and neonatal single-dose nevirapine com-
pared with Zidovudine for prevention of mother-to-child
transmission of HIV-+ in Kampala, Uganda : HIVNET
*+, randomised trial. Lancet -/. : 13/�2*,, +333.
-/� Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY,Coovadia HM, for the South African Vitamin A Study
Group : Method of feeding and transmission of HIV-+
from mothers to children by +/ months of age : prospec-
tive cohort study from Durban, South Africa. AIDS +/ :
� ,, �
N Wakasugi : Mother to Child Transmission of HIV in Africa
1.
-13�-21, ,**+.
-0� Mirochnick M, Clarke DF, Dorenbaum A : NevirapinePharmacokinetic considerations in children and pregnant
women. Clin Pharmacokinet -3 : ,2+�,3-, ,***.
-1� Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P,Fowler MG, Jackson JB : Cost e#ectiveness of single-
dose nevirapine regimen for mothers and babies to de-
crease vertical HIV-+ transmission in sub-Saharan
Africa. Lancet -/. : 2*-�2*3, +333.
-2� WHO Collaborative Study Team on the Role of Breast-feeding on the Prevention of Infant Mortality : E#ect of
breastfeeding on infant and child mortality due to infec-
tious diseases in less developed countries : a pooled anal-
ysis. Lancet -// : ./+�.//, ,***.
-3� Bassett MT : Psychosocial and community perspectiveson alternatives to breastfeeding. Ann N Y Acad Sci 3+2 :
+,2�+-/, ,***.
.*� Nduati R, John G, Mbori-Ngacha D : E#ect of breast
feeding and formula feeding on transmission of HIV-+
�A randomized clinical trial. JAMA ,2- : ++01�++1.
,***.
.+� King FS : Helping Mothers to Breastfeed. +st edition
+32/. Association for Consumers Action on Safety and
Health.
.,� Georgeson J, Filteau S : Physiology, immunology, anddisease transmission in human breast milk. AIDS PA-
TIENT CARE and STDs. +. : /--�/-3, ,***.
.-� Short and long term e#ects of breast feeding on child
health, (Koletzko B, Michaelsen KM, Hernell O eds),
Advances in Experimental Medicine and Biology, vol
.12. Kluwer Academic/Plenum Publishers, ,***.
..� Smith MM, Kuhn L : Exclusive breast-feeding : Does ithave the potential to reduce breast-feeding transmission
of HIV-+? Nutrition Reviews /2 : ---�-.*, ,***.
./� Willumsen JF, Filteau SM, Coutsoudis A, Uebel KE,Newell KE, Tomkins AM : Subclinical mastitis as a risk
factor for mother-infant HIV transmission. Advances in
Experimental Medicine and Biology .12 : ,++�,,-,
,***.
.0� Nduati R, Richardson BA, John G : E#ect of breastfeed-
ing on mortality among HIV-+ infected women : a
randomized trial. Lancet -/1 : +0/+�+0//, ,**+.
.1� Riley LE, Greene MF : Elective cesarean delivery toreduce the transmission of HIV. N Engl J Med -.* :
+*-,�+*--, +333.
.2� Jackson JB, Becker-Pergola G, Guay L : Identificationof the K+*-N mutation in Ugandan women receiving
nevirapine to prevent HIV-+ vertical transmission. AIDS
+. : +++�++/, ,***.
.3� New Data on the Prevention of Mother-to-Child Trans-mission of HIV and their Policy Implications. Conclu-
sions and recommendations. WHO Technical Consulta-
tion on behalf of the UNFPA/UNICEF/WHO/
UNAIDS Inter-Agency Task Team on Mother-to-Child
Transmission of HIV. Geneva, ++�+- October ,***.
/*� Eshelman SH, Mrancna M, Guay LA, Deseyve M,Cunningham S, Mirochnick M, Musoke P, Fleming T,
Fowler MG, Mofenson LM, Mmiro F, Jackson JB :
Selection and fading of resistance mutation in women
and infants receiving nevirapine to prevent HIV-+ verti-
cal transmission (HIVNET*+,). AIDS +/ : +3/+�+3/1,
,**+.
The Journal of AIDS Research Vol. . No. , ,**,
� ,- �1/